Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral blood stem cell implantation plus radial shortening osteotomy for Kienböck disease
IRCT20221223056902N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of peripheral blood stem cells in Kienböck disease (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Range of motion of the wrist and Radiological symptoms. Started Oct 2023; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
Kienböck disease
Beyond the preview
Go deeper on IRCT20221223056902N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221223056902N1.